N.E.W. Advisory Services LLC Cytosorbents Corp Put Options Transaction History
N.E.W. Advisory Services LLC
- $1.25 Billion
- Q1 2025
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding CTSO
# of Institutions
55Shares Held
17.2MCall Options Held
8.1KPut Options Held
6.9K-
Avenir Corp Washington, DC5.04MShares$4.74 Million0.55% of portfolio
-
Skylands Capital, LLC3MShares$2.82 Million0.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.83 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.58 Million0.0% of portfolio
-
Cm Management, LLC954KShares$896,8311.04% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $41M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...